Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Atherosclerosis. 2008 Apr 18;202(1):76–83. doi: 10.1016/j.atherosclerosis.2008.04.010

Fig. 2.

Fig. 2

(A) Representative RT-PCR gel of TLR2 mRNA in human monocytes following Pam3CSK4 exposure with or without candesartan as described in Section 2. (B) Representative RT-PCR gel of TLR4 mRNA in human monocytes following LPS exposure with or without candesartan as described in Section 2. (C) Quantitative analysis of TLR2 and TLR4 mRNA by densitometry. Values are normalized to β-actin mRNA. *P < 0.05 vs. control; **P < 0.05 vs. LPS/PAM3CSK4; n = 4 experiments in duplicate.